MILLENNIUM BIORESEARCH, INC

Millennium Bioresearch, Inc. specializes in advanced toxicological testing and preclinical research, with a primary focus on developing and implementing alternative testing strategies. Their core capabilities include acute oral toxicity categorization using egg LD50 assays, ocular irritation testing through integrated in vitro and alternative strategies, and the evaluation of photogenotoxicity using 3D tissue models. The company possesses technical expertise in local lymph node assays with IL-18 endpoints, the use of confocal microscopy on cultured porcine corneas, and the execution of single-dose intraperitoneal toxicity studies. The company maintains a strong operational relationship with the Department of Health and Human Services, where they provide specialized assay development and ocular testing strategies. They also support the Department of Agriculture and the Department of Defense, performing acute injection toxicity and pathogenicity studies, as well as other specialized scientific services. Their industry focus is centered on testing laboratories and scientific and technical consulting services. They operate at the intersection of biological product manufacturing and preclinical safety assessment, specializing in the development of replacement ocular batteries and alternative methods to traditional toxicity testing. Based in Spinnertown, Pennsylvania, Millennium Bioresearch, Inc. is structured as a 2L entity and holds an A2 certification.